Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'

Br J Cancer. 2014 Jan 7;110(1):267-8. doi: 10.1038/bjc.2013.737. Epub 2013 Dec 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androstenols / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Diethylstilbestrol / therapeutic use*
  • Estrogens, Non-Steroidal / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Steroid 17-alpha-Hydroxylase / antagonists & inhibitors*

Substances

  • Androstenols
  • Estrogens, Non-Steroidal
  • Diethylstilbestrol
  • Steroid 17-alpha-Hydroxylase